Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Pulmonary arterial hypertension associated with congenital heart disease
An overview of the demographics, pathophysiology and treatment of PAH-CHD is given and individuals with Down's syndrome are focused on as an important and challenging patient group.
Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification: Results From the First Multicenter Global Registry.
Standalone balloon aortic valvuloplasty: Indications and outcomes from the UK in the transcatheter valve era
- M. Khawaja, M. Sohal, +24 authors D. Hildick-Smith
- MedicineCatheterization and cardiovascular interventions…
- 1 February 2013
This work sought to characterize UK‐wide balloon aortic valvuloplasty (BAV) experience in the TAVI era and found that the BAV experience was dominated by fear and tremor.
Percutaneous Device Closure of Paravalvular Leak: Combined Experience From the United Kingdom and Ireland.
Percutaneous closure of PVL is an effective procedure that improves PVL severity and symptoms and is independently associated with both MACE and death.
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification.
- M. Guerrero, M. Urena, +54 authors T. Feldman
- MedicineJournal of the American College of Cardiology
- 1 May 2018
BACKGROUND The risk of surgical mitral valve replacement in patients with severe mitral annular calcification (MAC) is high. Several patients worldwide with severe MAC have been treated successfully…
Percutaneous device closure of atrial septal defect results in very early and sustained changes of right and left heart function.
Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease.
- O. Monfredi, L. Griffiths, B. Clarke, V. Mahadevan
- MedicineThe American journal of cardiology
- 15 November 2011
Patients with PAH-CHD without Down syndrome gain long-term symptomatic benefits in exercise capacity after bosentan treatment, and men seem to benefit more on bosENTan treatment.
Age‐ and Lesion‐Related Comorbidity Burden Among US Adults With Congenital Heart Disease: A Population‐Based Study
- A. Agarwal, Robert Thombley, +7 authors R. Dudley
- MedicineJournal of the American Heart Association
- 2 October 2019
Clinicians caring for adults with CHD may want to use a multidisciplinary approach, including building close collaborations with internists and specialists, to help provide appropriate care for the highly prevalent noncardiovascular comorbidities.
Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity.
A guide for identification and continuing care of adult congenital heart disease patients in primary care.
- S. Ellison, J. Lamb, +7 authors V. Mahadevan
- MedicineInternational journal of cardiology
- 10 March 2013
The ACHD Toolkit could help to improve quality, timeliness of care, patient experience and wellbeing, and a wide disparity of provision between current and optimal management strategies is illustrated.